Multidimensional Objective Measurement for Pain with Ecological Momentary Assessment

Multidimensional Objective Measurement for Pain with Ecological Momentary Assessment - MOM Pain EMA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042615

Enrollment

Registered

2021-01-11

Start date

2021-01-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Primary Pain or Chronic Secondary Musculoskeletal Pain

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Chronic Primary Pain or Chronic Secondary Musculoskeletal Pain. Lasting pain over three months at registration.

Exclusion criteria

Exclusion criteria: Comorbid conditions of infection, trauma, and other acute inflammatory conditions. The severe decline of cognitive function such as dementia. Having a skin disorder at the inspection site of pQST.

Design outcomes

Primary

Measure	Time frame
the association between pain intensity and physical activity measures in individuals with chronic primary pain or chronic secondary musculoskeletal pain	—

Secondary

Measure	Time frame
The association between pain intensity measured by the EMA and pain sensitization measured by pQST. The intraday variability of subjective symptoms (e.g., pain, stress, depressive mood) measured by the EMA. The interrelationships among subjective symptoms measured by the EMA. The associations between subjective symptoms measured by the EMA and questionnaire scores. The intraday variability of physical activity measured by the wearable accelerometer. The associations between subjective symptoms measured by the EMA and physical activity measured by the wearable accelerometer. The associations between physical activity measured by the wearable accelerometer and questionnaire scores.	—

Measure

Time frame

The association between pain intensity measured by the EMA and pain sensitization measured by pQST. The intraday variability of subjective symptoms (e.g., pain, stress, depressive mood) measured by the EMA. The interrelationships among subjective symptoms measured by the EMA. The associations between subjective symptoms measured by the EMA and questionnaire scores. The intraday variability of physical activity measured by the wearable accelerometer. The associations between subjective symptoms measured by the EMA and physical activity measured by the wearable accelerometer. The associations between physical activity measured by the wearable accelerometer and questionnaire scores.

—

Countries

Japan

Contacts

Public ContactSei Fukui

Shiga University of Medical Science Pain Management Clinic

sei@belle.shiga-med.ac.jp077-548-2582

Outcome results